Newman Ferrara LLP Announces Corporate Governance Investigations of Instil Bio, Inc. (TIL)
12 Dicembre 2022 - 5:45PM
Business Wire
Newman Ferrara LLP announced today that the firm is conducting
investigations on behalf of shareholders of Instil Bio, Inc.
(NASDAQ:TIL) (“Instil” or the “Company”). The investigations
concern whether certain of the Instil’s officers and directors
breached their fiduciary duties to shareholders, by, among other
things: (i) engaging in self-dealing; (ii) affirmatively approving
transactions that harmed the Company; and (iii) failing to provide
sufficient oversight of the Company’s business practices.
Current stockholders of Instil that seek more information on
this matter are invited to contact Newman Ferrara attorneys Jeffrey
Norton (jnorton@nfllp.com) or Benjamin Baker (bbaker@nfllp.com) to
discuss this investigation and their rights.
Newman Ferrara maintains a multifaceted practice based in New
York City with attorneys specializing in complex commercial and
multi-party litigation, securities fraud and shareholder
litigation, consumer protection, civil rights, and real estate. For
more information, please visit the firm website at
www.nfllp.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221212005645/en/
Newman Ferrara LLP Jeffrey M. Norton jnorton@nfllp.com 1250
Broadway, 27th Fl. New York, NY 10001 (212) 619-5400
Grafico Azioni Instill Bio (NASDAQ:TIL)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Instill Bio (NASDAQ:TIL)
Storico
Da Mag 2023 a Mag 2024